News

Novo Nordisk ends collaboration with Hims & Hers over weight loss drug
Novo Nordisk said in a statement on Monday that direct access to Wegovy would no longer be available to Hims & Hers Health ...
Maker of Ozempic and Wegovy broke advertising rules, regulator finds
The maker of weight loss drugs Ozempic and Wegovy broke rules around the advertising and marketing of its medication to healthcare workers over three years, the medicines watchdog has found.
Amgen gears up for phase 3 trial of monthly weight-loss drug MariTide amid mixed investor sentiment
Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...
Long Island experts weigh in after Novo Nordisk ends deal with Hims & Hers over weight loss meds
Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...
Novo Nordisk ends Hims & Hers collaboration over Wegovy weight loss drug
Novo Nordisk said on Monday it would halt its collaboration with U.S. telehealth company Hims & Hers Health over the ...
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
Reuters3d
Data on Novo Nordisk experimental weight-loss drug show mostly mild side effects - Reuters
June 22 (Reuters) - Novo Nordisk , opens new tab on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that side effects were mainly mild-to ...
Data on Novo Nordisk experimental weight-loss drug show mostly mild side effects
(Reuters) -Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that side effects were mainly mild-to-moderate and other outcome ...